Raksh Pharmaceuticals FZCO · Dubai, United Arab Emirates

The world's medicine,
routed through Dubai.

Raksh Pharmaceuticals FZCO is the international trading arm of the Raksh group: a Dubai free-zone company moving clinically evaluated specialty pharmaceuticals from globally audited manufacturers to markets across the Middle East, Africa, Asia and beyond.

Follow the journey Speak with our team
0+years of combined pharmaceutical leadership
0therapeutic areas in the portfolio
0countries served through the group network
0international regulatory frameworks observed

The journey of a medicine

Every product we deliver travels one path.

From sourcing, to consolidation in Dubai, to regulatory clearance, to the patient. Follow it below, chapter by chapter.

It begins with evidence, and the people who insist on it.

Heritage & the group

A Dubai hub built on a decade of pharmaceutical trade

Raksh, from the Sanskrit रक्ष, means protection.

Our Rakshology · the philosophy behind the name

Raksh Pharmaceuticals FZCO is the Dubai-based trading company of the Raksh group, an extension of Raksh Life Care (est. 2019) and Uveda Life Sciences (est. 2014). From the United Arab Emirates it consolidates sourcing, export and distribution for the group's specialty portfolio, so that effective healthcare reaches every corner of society.

The company trades in research-based specialty pharmaceutical products backed by clinical evidence and strong regulatory compliance. Dubai's position between Europe, Africa and Asia places every partner within one direct lane of the group's supply network, led by a team with fourteen years of combined pharmaceutical experience.

"Healthcare should not be a privilege, but a basic right."

2014Uveda Life Sciences foundedThe foundation: evidence-led product marketing across international markets.
2019Raksh Life Care establishedA dedicated specialty-medicines company, headquartered in Noida, India.
TodayRaksh Pharmaceuticals FZCO, DubaiThe group's international trading hub, incorporated as a free-zone company in Dubai, serving a twenty-two country network.
Global scienceEmbracing the latest advancements in medicine and biotechnology.
Clinical rigourGrounding every product in evidence and real-world application.
Human-centric valuesPrioritising people, compassion and long-term impact.
Protection-driven innovationSolutions that safeguard communities, families and futures.

Our mission

To enhance global health outcomes by delivering scientifically advanced, clinically validated and accessible healthcare solutions, empowering lives, protecting futures and building healthier communities.

Our vision

To become a globally recognised leader in healthcare innovation: a world where modern healthcare is not limited by borders, affordability or access.

Research defines what we make. The portfolio is where it becomes medicine.

The portfolio

Twelve disciplines of care

From specialty medicine to everyday wellness: the official Raksh product portfolio, clinically evaluated across twelve disciplines.

RX·01

Gynaecology

Women’s health therapies across reproductive and hormonal care.

Specialty
RX·02

Rheumatology

Disease-modifying therapy for inflammatory joint disease.

Chronic care
RX·03

Diabetology

Modern glycaemic control and adjacent diabetic care.

Chronic care
RX·04

Orthopaedics

Musculoskeletal recovery, mobility and joint preservation.

Specialty
RX·05

Nephrology

Renal therapies through every stage of kidney disease.

Specialty
RX·06

Gastroenterology

Digestive-system care from acute treatment to maintenance.

Specialty
RX·07

Oncology

Access to critical cancer therapies with rigorous evidence.

Specialty
RX·08

Respiratory

Airway and pulmonary care for chronic conditions.

Chronic care
RX·09

Organ Transplantation

Supporting therapies for transplant medicine.

Critical care
RX·10

Probiotics & Prebiotics

Microbiome-support formulations with clinical backing.

Wellness
RX·11

Multivitamins & Minerals

Evidence-led nutritional supplementation.

Wellness
RX·12

General Healthcare

Everyday essentials for primary and preventive care.

Wellness
Scroll to browse the portfolio
From areas of therapy to the products on the shelf.

The products

Specialty brands, sourced from Europe

A selection from the current portfolio: clinically supported products spanning diabetic care, ocular health and bone health.

Daparak-10 and Daparak-M tablet packs

The Daparak® range

Daparak-10 (dapagliflozin 10 mg) and Daparak-M 500/1000 (dapagliflozin with extended-release metformin): modern oral therapy for type 2 diabetes, co-branded with Euro Pharma Distribution.

Diabetic careRx tabletsEuro Pharma Distribution

The range in the round

ACS hyaluronate acid 10 mg ophthalmic solution pack with pre-filled syringe

ACS – Hyaluronate Acid 10 mg

Ophthalmic viscoelastic solution in a 0.55 ml sterile pre-filled syringe, for intraocular use.

Eye health
ACS sodium hyaluronate and chondroitin sulphate ophthalmic solution pack with pre-filled syringe

ACS – Hyaluronate + Chondroitin

Sodium hyaluronate 30 mg with chondroitin sulphate 40 mg in a 0.5 ml pre-filled syringe.

Eye health
Calvit Gold calcium carbonate and vitamin D3 tablets pack

Calvit Gold

Calcium carbonate 1.5 g with cholecalciferol (vitamin D3 400 IU) for bone density and strength.

Bone health
Keep scrolling to rotate the range
Every product answers to the world's strictest regulators.

Quality & regulatory

Audited against six international frameworks

Our manufacturing partners hold approvals from the regulatory authorities that set the global benchmark for pharmaceutical quality.

WHO-GMPWorld Health Organization Good Manufacturing Practice certification.
USFDAUnited States Food & Drug Administration facility approval.
EU-GMPEuropean Union Good Manufacturing Practice standards.
MHRAMedicines & Healthcare products Regulatory Agency, United Kingdom.
TGATherapeutic Goods Administration, Australia.
PIC/SPharmaceutical Inspection Co-operation Scheme membership standards.
Every product is additionally registered with the national regulatory authority of each market in which it is supplied. Approval is verified locally, not assumed globally.
Pharma Outlook TOP Research-Based Speciality Products Marketer 2026 Raksh Life Care · Featured

In the press · the Raksh group

Recognised by Pharma Outlook among the top research-based specialty marketers

"Quality assurance and regulatory compliance form the backbone of Raksh Life Care's operational philosophy."

The feature profiles Raksh Life Care as a global specialty pharmaceutical company connecting innovative manufacturers with markets that lack direct access to advanced therapies, narrowing global healthcare disparities across more than 22 countries.

  • Supply partnerships with leading manufacturers across France, Italy, Austria, Taiwan and India, including Reliance Life Sciences and Lupin.
  • Active market-entry plans for the United States, Canada and Saudi Arabia.
  • A consumer skincare brand in preparation, extending from specialty pharma into science-backed wellness.
Kshitij Gupta, Managing Director and CEO of Raksh Life Care
Kshitij Gupta Managing Director & CEO · as featured in Pharma Outlook
Approval is a passport. Twenty-two countries have stamped it.

Global reach, from Dubai

A twenty-two country network

0 countries where Raksh group products hold national approval

Middle East

United Arab EmiratesLebanonSyriaIraq

Africa

NigeriaDR CongoSouth Africa

Asia-Pacific

PhilippinesThailandVietnamMyanmarMalaysiaSingaporeAustraliaNew Zealand

South Asia

Sri LankaMaldives

Central Asia

UzbekistanTajikistanAfghanistan

Europe

Ukraine

Latin America

ChileGuatemala
Behind every market entry stands a full-service partner.

Services

One partner, end to end

Research-based products, global-standard manufacturing, end-to-end marketing and distribution, with accessibility and affordability at the centre.

SV·01 Product sourcing & licensing We identify, source and license high-quality pharmaceutical and nutraceutical products from globally recognised manufacturers.
SV·02 Regulatory support Comprehensive assistance with documentation, approvals and compliance to meet local and international regulatory standards.
SV·03 Marketing & brand development Strategic marketing, brand positioning and promotional support to establish and grow product visibility in target markets.
SV·04 Distribution & supply chain Efficient logistics and consolidation through the Dubai free-zone hub, ensuring timely and secure delivery across regions.
SV·05 Market expansion & entry strategy Tailored strategies that help partners penetrate new markets and scale operations globally.
SV·06 Technical & scientific support In-depth product training, scientific detailing and clinical data sharing to support informed decisions.
Every new market begins with a single conversation.

Partnership

Bring valued medicines to your market

We protect lives. We deliver trust. We build healthier futures.

Distributors, hospital networks and research partners, we should talk.

Registration, supply and co-marketing across regulated markets, handled by a team that has done it twenty-two times over.

Write to our team
Raksh Pharmaceuticals FZCO
Dubai Silicon Oasis, Dubai Digital Park,
Dubai, United Arab Emirates
+91 98186 88862 info@rakshpharma.ae